Ken Griffin
LEXX icon

Ken Griffin’s Lexaria Bioscience LEXX Stock Holding History

Ken Griffin’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
+901
New +$9.81K ﹤0.01% 12750
2024
Q2 		– Sell
-1,057
Closed -$57.6K – 14932
2024
Q1 		$57.6K Sell
1,057
-914
-46% -$34.9K ﹤0.01% 12042
2023
Q4 		$37K Buy
+1,971
New +$38.1K ﹤0.01% 12078
2023
Q1 		– Sell
-1,245
Closed -$45.8K – 15140
2022
Q4 		$45.8K Sell
1,245
-413
-25% -$14.8K ﹤0.01% 12244
2022
Q3 		$61K Sell
1,658
-201
-11% -$8.59K ﹤0.01% 11488
2022
Q2 		$83K Buy
+1,859
New +$74.7K ﹤0.01% 11568
2021
Q2 		– Sell
-994
Closed -$84K – 14073
2021
Q1 		$84K Buy
+994
New +$87.4K ﹤0.01% 12607

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Ken Griffin's LEXX Position: Q1 2026 in Review

Ken Griffin opened a new position in Lexaria Bioscience (LEXX) in Q1 2026: 901 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #12750 among its holdings. This is a return to the name: Ken Griffin previously reported a position in LEXX as recently as Q1 2024.

Ken Griffin first reported a position in LEXX in Q1 2021 and has held it in 7 quarters since. The position peaked at $84K in Q1 2021. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Ken Griffin held 901 shares of Lexaria Bioscience worth $10.5K as of Q1 2026.
  • Lexaria Bioscience was a new Ken Griffin position in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12750 holding.
  • Ken Griffin first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 7 quarters since.
  • Ken Griffin's Lexaria Bioscience position peaked at $84K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.